As the known endothelial cells specific RTKs along with the vascular endothelial growth factor (VEGF) receptor, Tie-2 belongs to the Tie family of endothelial-specific receptor tyrosine kinases which plays a key role in cell proliferation, migration and survival during angiogensis. Tie-2 is predominantly expressed on vascular endothelial cells and binds all the known angiopoietin (ANGPT) ligands is a receptor for the angiopoietin (ANG) family: ANG-1, ANG-2, and ANG-3. The Tie-2 receptor and the angiopoietins as important regulators of tumor-induced angiogenesis and, therefore, cancer growth and metastasis. Activated Tie-2 activates several other effectors including endothelial nitric oxide synthase (eNOS), SH2 domain-containing phosphatase (SHP2), growth factor receptor-bound protein 2 (GRB2), the p85 subunit of PI3K.
| Cat.No. | Product Name | Information | Publication | Customer Review |
|---|---|---|---|---|
| S1361 | MGCD-265 | MGCD-265 is a potent, multi-target and ATP-competitive inhibitor of c-Met, VEGFR1, VEGFR2, VEGFR3, Ron, and Tie2 with IC50 of 1 nM, 3 nM, 3 nM, 4 nM, 2 nM and 7 nM, respectively. |
|
|
| S1577 | Tie2 kinase inhibitor | Tie2 kinase inhibitor is a potent and selective Tie2 inhibitor with IC50 of 0.25 μM. |
(1)
|
|

(1)
